GB867880A - N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the same - Google Patents
N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the sameInfo
- Publication number
- GB867880A GB867880A GB367858A GB367858A GB867880A GB 867880 A GB867880 A GB 867880A GB 367858 A GB367858 A GB 367858A GB 367858 A GB367858 A GB 367858A GB 867880 A GB867880 A GB 867880A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bis
- compounds
- acetylamino
- acid
- tri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention comprises compounds of the general formula: <FORM:0867880/IV (b)/1> and their non-toxic salts with organic or inorganic bases, where X is a methylene or polymethylene group which may be substituted by alkyl or phenyl groups, ac is an acyl radical preferably of an aliphatic carboxylic acid of which the acyl group contains 1-6 carbon atoms. The compounds may be prepared by 3:5-dinitrobenzoylating the amino group of the required amino acid e.g. by reaction with 3:5 dinitrobenzoyl chloride by a Schotten-Baumann reaction, and reducing the acylation product to the corresponding 3:5 diaminobenzoyl product, which is then tri iodinated preferably by means of iodine monochloride in hydrochloric acid, and then N-acylated on both of the amino groups. Examples are given of the preparation of 3:5-bis (acetylamino)-2:4:6-tri-iodo hippuric acid, 3:5-bis (acetylamino)-2:4:6-tri-iodobenzoyl-N-d: 1-leucine, 3: 5-bis (propionylamino)-2:4:6-tri-iodo hippuric acid, 3:5-bis (formylamino)-2:4:6-tri-iodohippuric acid, 3:5-bis (acetylamino)-2:4:6-tri-iodobenzoyl-N-d:1-alanine, and N-[3:5 bis-(acetylamino)-2:4:6 tri-iodobenzoyl]-a -aminophenyl acetic acid and the corresponding unacylated compounds. Methyl glucamine salts of the acylated compounds are specified.ALSO:Compounds of the general formula <FORM:0867880/VI/1> (where X is a methylene or polymethylene group, which may be substituted by alkyl or phenyl groups, and ac is an acyl radical), and non-toxic salts of these compounds with organic or inorganic bases, are used in X-ray contrast media. Compounds specified are 3 : 5-bis-(acetylamino) - 2 : 4 : 6 - triiodo hippuric acid and the corresponding formylamino and propionylamino compounds, 3 : 5-bis-(acetylamino)-2 : 4 : 6 - triiodobenzoyl - N - d : l - leucine and the corresponding d : l-alanine compound, and N - [3 : 5 - bis - (acetylamino) - 2 : 4 : 6 - triiodobenzoyl] - a - aminophenylacetic acid. The compounds may be used with a diluent, and other constituents may be included in the preparation of the X-ray contrast media. In examples compositions are prepared by mixing 3 : 5 - bis - (acetylamino) - 2 : 4 : 6 - triiodo hippuric acid with methyl glucamine and water, and by mixing the methyl glucamine salt of the above hippuric acid compound with sodium citrate, the sodium salt of ethylene diamine tetra-acetic acid, and water.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESCH21689A DE1125587B (en) | 1957-03-06 | 1957-03-06 | X-ray contrast media |
Publications (1)
Publication Number | Publication Date |
---|---|
GB867880A true GB867880A (en) | 1961-05-10 |
Family
ID=7429122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB367858A Expired GB867880A (en) | 1957-03-06 | 1958-02-04 | N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the same |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE564991A (en) |
DE (1) | DE1125587B (en) |
FR (1) | FR1282518A (en) |
GB (1) | GB867880A (en) |
NL (1) | NL104758C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953501A (en) * | 1972-02-16 | 1976-04-27 | Schering Aktiengesellschaft | Triiodoisophthalic acid monoamino acid amides |
US4607123A (en) * | 1984-02-29 | 1986-08-19 | Dr. Franz Kohler Chemie Gmbh | Water soluble 3,5-diacetamido-2,4,6-triiodobenzoic acid derivatives |
EP0810858A2 (en) * | 1994-12-27 | 1997-12-10 | The Du Pont Merck Pharmaceutical Company | Boronic acid and ester inhibitors of thrombin |
JP2009521467A (en) * | 2005-12-23 | 2009-06-04 | ジーランド ファーマ アクティーゼルスカブ | Modified lysine mimetic compounds |
WO2024093387A1 (en) * | 2022-11-01 | 2024-05-10 | 科睿驰(深圳)医疗科技发展有限公司 | Contrast compound and method for preparing same, and imageable embolization material and method for preparing same |
-
1957
- 1957-03-06 DE DESCH21689A patent/DE1125587B/en active Pending
-
1958
- 1958-02-04 NL NL224625A patent/NL104758C/xx active
- 1958-02-04 GB GB367858A patent/GB867880A/en not_active Expired
- 1958-02-17 FR FR758437A patent/FR1282518A/en not_active Expired
- 1958-02-20 BE BE564991D patent/BE564991A/xx unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953501A (en) * | 1972-02-16 | 1976-04-27 | Schering Aktiengesellschaft | Triiodoisophthalic acid monoamino acid amides |
US4607123A (en) * | 1984-02-29 | 1986-08-19 | Dr. Franz Kohler Chemie Gmbh | Water soluble 3,5-diacetamido-2,4,6-triiodobenzoic acid derivatives |
EP0810858A2 (en) * | 1994-12-27 | 1997-12-10 | The Du Pont Merck Pharmaceutical Company | Boronic acid and ester inhibitors of thrombin |
EP0810858A4 (en) * | 1994-12-27 | 2000-11-15 | Du Pont Pharm Co | Boronic acid and ester inhibitors of thrombin |
JP2009521467A (en) * | 2005-12-23 | 2009-06-04 | ジーランド ファーマ アクティーゼルスカブ | Modified lysine mimetic compounds |
WO2024093387A1 (en) * | 2022-11-01 | 2024-05-10 | 科睿驰(深圳)医疗科技发展有限公司 | Contrast compound and method for preparing same, and imageable embolization material and method for preparing same |
Also Published As
Publication number | Publication date |
---|---|
DE1125587B (en) | 1962-03-15 |
BE564991A (en) | 1960-07-15 |
FR1282518A (en) | 1962-01-27 |
NL104758C (en) | 1963-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3060434D1 (en) | Diamides of triiodo-isophthalic acids, their preparation and x-ray contrast agents containing them | |
BR9503582A (en) | Compound pharmaceutical composition use and method of treatment of a human | |
ES2057746T3 (en) | DTPA MONOAMIDES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURES FOR THEIR PREPARATION. | |
DE3062609D1 (en) | Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds | |
ES429234A1 (en) | N-(1-({107 -phenyl-alkyl)-piperidyl-4)-N-({60 -pyridyl)-carboxylic acid amides and salts thereof | |
GB867880A (en) | N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the same | |
ES505672A0 (en) | PROCEDURE FOR THE PREPARATION OF OXIMES OF PYRUTICAL ACIDS | |
GB767788A (en) | Polyiodinated phenyl fatty acid compounds and process for their manufacture | |
US4264572A (en) | X-ray contrast media | |
PT643061E (en) | NEW ANTIBIOTICS OF CEFALOSPORINA AND PROCESSES FOR THEIR PREPARATION | |
US4107286A (en) | Polyiods benzene derivatives and X-ray contrast media containing the same | |
ES8607910A1 (en) | Tertiary amines. | |
GB881510A (en) | Iodine-containing benzoic acid amides and a method of producing same | |
GB785670A (en) | Improvements in or relating to chemical compounds for use as x-ray diagnostic agentsand to processes for their preparation | |
GB912920A (en) | New substituted aminomethanephosphonic acids and processes for their production | |
Hozumi et al. | Induction of erythroid differentiation in murine erythroleukemia cells by N‐substituted polymethylene diamides | |
GB898909A (en) | New naphthalene compounds and process for their manufacture | |
SE303829B (en) | Injectable X-ray contrast agent composition | |
GB1271054A (en) | Isoindoline and benzoisothiazoline derivatives, their preparation and pharmaceutical compositions containing them | |
JPS57192347A (en) | N-(4-(3-aminopropyl)aminobutyl)-2,2-dihydroxyethanamide and its synthesis | |
US4152526A (en) | N-acyl derivatives of 3-amino-2,4,6-triiodobenzoic acid | |
JP2540602B2 (en) | Fluorine-containing amide compound | |
GB994215A (en) | Isophthalic acid derivatives and process for preparing same | |
GB867538A (en) | Nuclear iodinated ª-ú¦ª--bis-(aminophenyl)-propionic acids and x-ray contrast media comprising the same | |
ES8505981A1 (en) | 1-Phenylalkyl-4-(mercapto and carbamylthio)alkyl-piperazines and -homopiperazines and their use in the treatment of allergic diseases. |